Statistics

Total Visits

Views
Pharmacoeconomic evaluation of tocilizumab monotherapy versus adalimumab monotherapy in reducing disease activity in patients with rheumatoid arthritis37

Select a period of time:

Number of views in the range

Views
Pharmacoeconomic evaluation of tocilizumab monotherapy versus adalimumab monotherapy in reducing disease activity in patients with rheumatoid arthritis29

Views

Views
March 202515
April 202512
May 20251
June 20250
July 20251
August 20250
September 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore15
Hong Kong10
United States2
Spain1
Mexico1
 

Top cities views

Views
Hong Kong10
Apizaco1
Council Bluffs1
Cranston1